FLAGSTAFF, Ariz., Aug. 1, 2019 /PRNewswire/ -- SenesTech, Inc.
(NASDAQ: SNES), a developer of proprietary technologies for
managing animal pest populations through fertility control, will
report financial results for its second quarter of 2019, ended
June 30, 2019, after the market close
on Tuesday, August 13, 2019. The
Company has scheduled a conference call that same day, Tuesday, August 13, 2019, at 5:00 pm ET, to review the results.
Second Quarter 2019 Conference Call Details
Date and Time: Tuesday, August 13,
2019 at 5:00 pm ET
Call-in Information: Interested parties can access the
conference call by dialing (844) 308-3351 or (412) 317-5407.
Live Webcast Information: Interested parties can access
the conference call via a live Internet webcast, which is available
in the Investor Relations section of the Company's website at
http://senestech.investorroom.com/.
To Ask a Question: There will be three options to ask a
question during the call:
- Questions can be asked live during the call-in portion of the
conference call.
- The live webcast will feature an option to submit questions in
writing during the event.
- If you are unable to attend the event, you can submit a
question in advance to Senestech@LythamPartners.com.
Replay: A teleconference replay of the call will be
available for three days at (877) 344-7529 or (412) 317-0088,
confirmation #10134038. A webcast replay will be available in the
Investor Relations section of the Company's website at
http://senestech.investorroom.com/ for 90 days.
About SenesTech
SenesTech is changing the paradigm of
pest management by targeting the root cause of the problem:
reproduction.
ContraPest® is an innovative technology with an approach that
targets the reproductive capabilities of both sexes in rat
populations, inducing egg loss in female rats and impairing sperm
development in males. Using a proprietary bait delivery method,
ContraPest® is dispensed in a highly palatable liquid formulation
that promotes sustained consumption by rat communities. ContraPest®
is designed, formulated and dispensed to be low hazard for handlers
and non-target species such as wildlife, livestock and pets, where
the active ingredients break down rapidly.
We believe ContraPest® will establish a new paradigm in rodent
control, resulting in a decreased reliance on lethal options. For
more information visit the SenesTech website at
www.senestech.com.
Safe Harbor Statement
This release contains
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"may," "future," "plan" or "planned," "will" or "should,"
"expected," "anticipates," "draft," "eventually" or "projected."
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors and other risks
identified in our filings with the Securities and Exchange
Commission. Forward looking statements include, but are not limited
to, our expectation regarding sales commitments, our expectation
regarding the conversion of sales commitments and programs to
revenue, our belief that our product is more humane, less harmful
to the environment and more effective than traditional methods, and
our belief that ContraPest will establish a new paradigm in rodent
control without environmental effects of rodenticides. All
forward-looking statements contained in this press release speak
only as of the date on which they were made and are based on
management's assumptions and estimates as of such date. We do not
undertake any obligation to publicly update any forward-looking
statements, whether as a result of the receipt of new information,
the occurrence of future events or otherwise.
CONTACT:
Investor: Robert Blum, Lytham
Partners, LLC, 602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc., 928-779-4143
View original content to download
multimedia:http://www.prnewswire.com/news-releases/senestech-inc-to-report-second-quarter-2019-financial-results-on-tuesday-august-13-2019-300894663.html
SOURCE SenesTech, Inc.